Synthesis of benzimidazole derivatives using Ni2+ supported on hydroxyapatite-core@shell γ-Fe2O3 nanoparticles both under solvent and solvent-free conditions
Authors
Abstract:
Ni2+ supported on hydroxyapatite-core@shell γ-Fe2O3 nanoparticles (γ-Fe2O3@HAp-Ni2+) was found to be a useful catalyst for the synthesis of benzimidazole derivatives from o-phenylenediamine and aldehydes under solvent and solvent-free conditions at 80 °C. This reaction affords the corresponding benzimidazole derivatives compared with the classical reactions this method consistently gives a high yield, easy magnetic separation, a short reaction time, simple workup and recyclable property of the catalyst. In this way, the catalyst was readily recovered using an external magnet and could be reused in five consecutive runs without significant loss of reactivity. The mean size and the surface morphology of the nanocatalyst were characterized by TEM, SEM, VSM, XRD and FTIR techniques.
similar resources
synthesis of benzimidazole derivatives using ni2+ supported on hydroxyapatite-core@shell γ-fe2o3 nanoparticles both under solvent and solvent-free conditions
ni2+ supported on hydroxyapatite-core@shell γ-fe2o3 nanoparticles (γ-fe2o3@hap-ni2+) was found to be a useful catalyst for the synthesis of benzimidazole derivatives from o-phenylenediamine and aldehydes under solvent and solvent-free conditions at 80 °c. this reaction affords the corresponding benzimidazole derivatives compared with the classical reactions this method consistently gives a high...
full textNi2+ supported on hydroxyapatite-core@shell γ-Fe2O3 nanoparticles as new and green catalyst for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones under solvent-free condition
The aim of this research is to study Ni2+ supported on hydroxyapatite-core-shell magnetic γ-Fe2O3 nanoparticles (γ-Fe2O3@HAp-Ni2+) as a green and recyclable catalyst for the Biginelli reaction under solvent-free conditions. One-pot multi-component condensation of 1,3-dicarbonyl compounds, urea and aldehydes at 80 oC affords the corresponding compounds in high yields and in short reaction times ...
full textChemoselective Synthesis of 1,1-diacetate Using Ni2+@ Hydroxyapatite-core@shell γ-Fe2O3 Nanoparticles as an Efficient and Reusable Lewis Acid Catalyst under Solvent Free Conditions
A simple and efficient method for the chemoselective 1,1-diacetate protection of aromatic aldehydes with acetic anhydride by using Ni2+ supported on hydroxyapatite-core-shell magnetic γ-Fe2O3 nanoparticles (γ-Fe2O3@HAp-Ni2+) under solvent free conditions. This method has several advantages, including high yield, short reaction time, simple work-up and recyclable property of the catalyst. The ca...
full textni2+ supported on hydroxyapatite-core@shell γ-fe2o3 nanoparticles as new and green catalyst for the synthesis of 3,4-dihydropyrimidin-2(1h)-ones under solvent-free condition
the aim of this research is to study ni2+ supported on hydroxyapatite-core-shell magnetic γ-fe2o3 nanoparticles (γ-fe2o3@hap-ni2+) as a green and recyclable catalyst for the biginelli reaction under solvent-free conditions. one-pot multi-component condensation of 1,3-dicarbonyl compounds, urea and aldehydes at 80 oc affords the corresponding compounds in high yields and in short reaction times ...
full textchemoselective synthesis of 1,1-diacetate using ni2+@ hydroxyapatite-core@shell γ-fe2o3 nanoparticles as an efficient and reusable lewis acid catalyst under solvent free conditions
a simple and efficient method for the chemoselective 1,1-diacetate protection of aromatic aldehydes with acetic anhydride by using ni2+ supported on hydroxyapatite-core-shell magnetic γ-fe2o3 nanoparticles (γ-fe2o3@hap-ni2+) under solvent free conditions. this method has several advantages, including high yield, short reaction time, simple work-up and recyclable property of the catalyst. the ca...
full textMy Resources
Journal title
volume 5 issue 4
pages 305- 309
publication date 2015-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023